Genetic epidemiology of lymphatic filariasis in American Samoa after mass drug administration

被引:2
|
作者
Hedtke, Shannon M. [1 ,2 ]
Zendejas-Heredia, Patsy A. [1 ]
Graves, Patricia M. [3 ]
Sheridan, Sarah [4 ]
Sheel, Meru [5 ]
Fuimaono, Saipale D. [6 ]
Lau, Colleen L. [4 ]
Grant, Warwick N. [1 ,2 ]
机构
[1] La Trobe Univ, Dept Anim Plant & Soil Sci, Bundoora, Vic, Australia
[2] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia
[3] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Cairns, Qld, Australia
[4] Australian Natl Univ, Res Sch Populat Hlth, Dept Global Hlth, Acton, ACT, Australia
[5] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Acton, ACT, Australia
[6] Amer Samoa Dept Hlth, Pago Pago, Samoa
基金
美国国家卫生研究院; 英国医学研究理事会; 比尔及梅琳达.盖茨基金会;
关键词
Lymphatic filariasis; American Samoa; Wuchereria bancrofti; Population genetics; Mass drug administration; WUCHERERIA-BANCROFTI; MOLECULAR EPIDEMIOLOGY; POPULATION-GENETICS; R-PACKAGE; PARASITE; NETWORKS; SEQUENCE; ISLANDS; DISEASE; AREAS;
D O I
10.1016/j.ijpara.2020.08.009
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Over 892 million people in 48 countries are at risk of infection by nematodes that cause lymphatic filariasis. As part of the Global Programme to Eliminate Lymphatic Filariasis, mass drug administration is distributed to communities until surveillance indicates infection rates are below target prevalence thresholds. In some countries, including American Samoa, lymphatic filariasis transmission persists despite years of mass drug administration and/or has resurged after cessation. Nothing is known about the population genetics of Wuchereria bancrofti worms in Polynesia, or whether local transmission is persisting and/or increasing due to inadequate mass drug administration coverage, expansion from residual hotspots, reintroduction from elsewhere, or a combination. We extracted DNA from microfilariae on blood slides collected during prevalence surveys in 2014 and 2016, comprising 31 pools of five microfilariae from 22 persons living in eight villages. We sequenced 1104 bp across three mitochondrial markers (ND4, COI, CYTB). We quantified parasite genetic differentiation using variant calls and estimated haplotypes using principal components analysis, F-statistics, and haplotype networks. Of the variants called, all but eight were shared across the main island of Tutuila, and three of those were from a previously described hotspot village, Fagali'i. Genotypic data did not support population genetic structure among regions or villages in 2016, although differences were observed between worms collected in Fagali'i in 2014 and those from 2016. Because estimated haplotype frequency varied between villages, these statistics suggested genetic differentiation, but were not consistent among villages. Finally, haplotype networks demonstrated American Samoan sequence clusters were related to previously published sequences from Papua New Guinea. These are, to our knowledge, the first reports of W. bancrofti genetic variation in Polynesia. The resurgent parasites circulating on the main island of American Samoa represent a single population. This study is the first step towards investigating how parasite population structure might inform strategies to manage resurgence and elimination of lymphatic filariasis. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.
引用
收藏
页码:137 / 147
页数:11
相关论文
共 50 条
  • [1] Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration
    Lau, Colleen L.
    Won, Kimberly Y.
    Becker, Luke
    Magalhaes, Ricardo J. Soares
    Fuimaono, Saipale
    Melrose, Wayne
    Lammie, Patrick J.
    Graves, Patricia M.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (11):
  • [2] Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration
    Coutts S.P.
    King J.D.
    Pa'au M.
    Fuimaono S.
    Roth J.
    King M.R.
    Lammie P.J.
    Lau C.L.
    Graves P.M.
    [J]. Tropical Medicine and Health, 45 (1)
  • [3] Molecular Xenomonitoring Using Mosquitoes to Map Lymphatic Filariasis after Mass Drug Administration in American Samoa
    Schmaedick, Mark A.
    Koppel, Amanda L.
    Pilotte, Nils
    Torres, Melissa
    Williams, Steven A.
    Dobson, Stephen L.
    Lammie, Patrick J.
    Won, Kimberly Y.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (08):
  • [4] Prevalance of Lymphatic Filariasis in American Samoa after three years of improved social mobilization and mass drug administration
    Liang, Jennifer L.
    King, Jonathan
    Pa'au, Molisamoa
    Ichimori, Kazuyo
    Lammie, Patrick
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 100 - 100
  • [5] Assessing Transmission of Lymphatic Filariasis Using Parasitologic, Serologic, and Entomologic Tools after Mass Drug Administration in American Samoa
    Mladonicky, Janice M.
    King, Jonathan D.
    Liang, Jennifer L.
    Chambers, Eric
    Pa'au, Molisamoa
    Schmaedick, Mark A.
    Burkot, Thomas R.
    Bradley, Mark
    Lammie, Patrick J.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 80 (05): : 769 - 773
  • [6] Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration
    Lau, Colleen L.
    Sheridan, Sarah
    Ryan, Stephanie
    Roineau, Maureen
    Andreosso, Athena
    Fuimaono, Saipale
    Tufa, Joseph
    Graves, Patricia M.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (09):
  • [7] Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration
    Mayfield, Helen J.
    Sartorius, Benn
    Sheridan, Sarah
    Howlett, Maddison
    Martin, Beatris Mario
    Thomsen, Robert
    Tofaeono-Pifeleti, Rossana
    Viali, Satupaitea
    Graves, Patricia M.
    Lau, Colleen L.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (06):
  • [8] Impact of a Mass Drug Administration Campaign Using a Novel Three-Drug Regimen on Lymphatic Filariasis Antigenemia - American Samoa, 2019
    Hast, Marisa A.
    Tufa, Aifili
    Brant, Tara A.
    Suiaunoa-Scanlan, Lynette
    Camacho, Janet
    Vaifanua-Leo, June
    Robinson, Keri
    Dodd, Emily
    Sili, Ben
    Lees, Loretta S.
    Won, Kimberly Y.
    Utu, Fara
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (21): : 656 - 657
  • [9] MONITORING THE IMPACT OF TWO ANNUAL ROUNDS OF MASS DRUG ADMINISTRATION USING A 3-DRUG REGIMEN ON LYMPHATIC FILARIASIS IN AMERICAN SAMOA
    Brant, Tara A.
    Tufa, Aifili
    Utu, Fara
    Tavale, Noelle
    Suiaunoa-Scanlan, Lynette
    Pele, Ula
    Vaifanua-Leo, June
    Sili, Benjamin
    Robinson, Keri
    Dodd, Emily A.
    Wiegand, Ryan E.
    Camacho, Janet
    Chutaro, Emi
    Won, Kimberly Y.
    Nua, Motusa Tuileama
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 113 - 113
  • [10] Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018-2019
    Willis, Gabriela A.
    Kearns, Therese
    Mayfield, Helen J.
    Sheridan, Sarah
    Thomsen, Robert
    Naseri, Take
    David, Michael C.
    Engelman, Daniel
    Steer, Andrew C.
    Graves, Patricia M.
    Lau, Colleen L.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2023, 17 (08):